Safinamide mesylate salt, >=98% (HPLC)

Safinamide mesylate salt, >=98% (HPLC)

Application

Safinamide mesylate salt may be used in cell signaling studies.

Safinamide mesylate salt has been used as a reference drug to study its inhibitory effect on human monoamine oxidases (hMAO-A and hMAO-B).

Biochem/physiol Actions

Safinamide mesylate prevents dopamine reuptake and is effective in the treatment of epilepsy and Parkinson′s disease.

Safinamide is a highly selective and reversible monoamine oxidase type B (MAO-B) inhibitor that increases neostriatal dopamine concentration. In addition, safinamide is voltage-dependent sodium and calcium channel blocker. It appears to bind to the batrachotoxin-sensitive site 2 of the voltage-sensitive sodium channels. Safinamide blocks N and L-type calcium channels and inhibits glutamate and aspartate release from synaptic terminals.

Features and Benefits

This compound is featured on the Calcium Channels and Dopamine and Norepinephrine Metabolism pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Form Assay Price Quantity
3573985 Safinamide mesylate salt, >=98% (HPLC) white to tan 100 YKOCHIUQOBQIAC-YDALLXLXSA-N 1S/C17H19FN2O2.CH4O3S/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14;1-5(2,3)4/h2-9,12,20H,10-11H2,1H3,(H2,19,21);1H3,(H,2,3,4)/t12-;/m0./s1 SIGMA-ALDRICH powder ≥98% (HPLC)
£596.14 (exc VAT) per 25MG
-
+
3573986 Safinamide mesylate salt, >=98% (HPLC) white to tan 100 YKOCHIUQOBQIAC-YDALLXLXSA-N 1S/C17H19FN2O2.CH4O3S/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14;1-5(2,3)4/h2-9,12,20H,10-11H2,1H3,(H2,19,21);1H3,(H,2,3,4)/t12-;/m0./s1 SIGMA-ALDRICH powder ≥98% (HPLC)
£182.46 (exc VAT) per 5MG
-
+